| 引用本文: | 赵婷慧,贡雪芃,向东,刘璐,李宁红,余恒毅,李喜平,杜光.LC-MS/MS测定人血浆中多黏菌素B浓度及其应用[J].中国现代应用药学,2022,39(23):3117-3122. |
| ZHAO Tinghui,GONG Xuepeng,XIANG Dong,LIU Lu,LI Ninghong,YU Hengyi,LI Xiping,DU Guang.Concentration Determination of Polymyxin B in Plasma by LC-MS/MS and Its Application[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(23):3117-3122. |
|
| 摘要: |
| 目的 建立测定人血浆中多黏菌素B总浓度的液相色谱串联质谱(LC-MS/MS)方法，并应用于临床多黏菌素B的治疗药物监测。方法 采用Welch Ultimate LP-C18(100mm×2.1mm，5μm)色谱柱对多黏菌素B的主要成分进行色谱分离，建立时间程序为4.0min的LC-MS/MS法，以乙腈为沉淀剂进行蛋白沉淀的样品前处理，用正离子扫描以及多反应监测模式进行分析物测定。结果 多黏菌素B的总浓度线性范围为100~10000ng·mL-1，各主要成分线性系数均>0.996，批内和批间精密度RSD均≤6%，准确度为91.88%~114.02%，测定3例使用多黏菌素B患者的体内暴露量，AUC0-24h分别为39.73，64.15，107.75mg·L-1·h-1。结论 本研究建立了一种稳健的测定人血浆中多黏菌素B总浓度的LC-MS/MS方法，灵敏度和特异性好，并成功用于临床上多黏菌素B的治疗药物监测。 |
| 关键词: 液相色谱串联质谱法 多黏菌素B 治疗药物监测 |
| DOI：10.13748/j.cnki.issn1007-7693.2022.23.010 |
| 分类号:R917.101 |
| 基金项目: |
|
| Concentration Determination of Polymyxin B in Plasma by LC-MS/MS and Its Application |
|
ZHAO Tinghui, GONG Xuepeng, XIANG Dong, LIU Lu, LI Ninghong, YU Hengyi, LI Xiping, DU Guang
|
|
Department of Pharmacy, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
|
| Abstract: |
| OBJECTIVE To establish a liquid chromatography tandem mass spectrometry(LC-MS/MS) method for the determination of polymyxin B concentration in human plasma, and to use it for clinical drug monitoring of polymyxin B. METHODS The Welch Ultimate LP-C18(100 mm×2.1 mm, 5 μm) column was used to separate the main components of polymyxin B, and an LC-MS/MS with a time program of 4.0 min was established. Acetonitrile was used as precipitator for sample pretreatment of protein precipitation, positive ion scanning and multi-reaction detection mode were used for analyte determination. RESULTS The linear range of total polymyxin B concentration was 100-10 000 ng·mL-1. The linear coefficients of the main components were both> 0.996. The intra-assay and inter-assay precisions were both ≤ 6%, and the accuracy was 91.88%-114.02%. The in vivo exposure of three patients using polymyxin B, AUC0-24 h was 39.73, 64.15 and 107.75 mg·L-1·h-1, respectively. CONCLUSION This study has established a robust LC-MS/MS method for the determination of the total concentration of polymyxin B in human plasma, with good sensitivity and specificity, and has been successfully used for clinical monitoring the concentration of polymyxin B. |
| Key words: LC-MS/MS polymyxin B therapeutic drug monitoring |
